Comparing the effect of a pain reducing agent(bupivacaine)adding another medicine(dexamethasone) which favours the action of bupivacaine versus bupivacaine alone, for pain relief injected near a nerve in the neck which is responsible for pain after a type of ear related surgery

Comparative evaluation of Bupivacaine 0.25% with Dexamethasone 2mg versus Bupivacaine 0.25% alone in greater auricular nerve block for post-operative analgesia in mastoid surgery

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/011899

Enrollment

Registered

2018-02-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Age group between 18 and 65years of either gender belonging to ASAPS 1 or 2 undergoing Mastoid surgery

Interventions

Intervention1: Group D: Greater auricular nerve block with 9.5ml of bupivacaine 0.25% and dexamethasone 2mg i.e 0.5ml Control Intervention1: Group S: Greater auricular nerve block with 9.5ml of bupiva

Eligibility

Inclusion criteria

Inclusion criteria: ASAPS 1 or 2 undergoing Mastoid surgery

Exclusion criteria

Exclusion criteria: Bleeding disorders On anticoagulant drugs Facial or other nerve palsy Infection,trauma, scar or sinuses at the site of block Known hypersensitivity to local anaesthetic drug Pregnant and lactating women Unable to speak or understand verbal command and VAS Unwilling to participate in the study Psychiatric illness

Design outcomes

Primary

Measure	Time frame
duration of analgesiaTimepoint: first 8 hours, hourly and then every 2 hours for 24 hours	—

Secondary

Measure	Time frame
requirement of rescue analgesicsTimepoint: every hour for first 8 hours and every 2 hours for 24 hours till VAS 4 or more	—

Countries

India

Contacts

Public ContactDr Rashmi Bawdekar

Kasturba Medical college and hospital

rashbawdekar@gmail.com09448866819

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026